(Q73132177)
Statements
Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma (English)
J S Du Bois
E G Trehu
J W Mier
L Shapiro
M Epstein
M Klempner
C Dinarello
K Kappler
L Ronayne
W Rand